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OBJECTIVE — To identify factors that inﬂuence survival after diabetes-related amputations.
RESEARCH DESIGN AND METHODS — We abstracted medical records of 1,043
hospitalized subjects with diabetes and a lower-extremity amputation from 1 January to 31
December1993insixmetropolitanstatisticalareasinsouthTexas.Weidentiﬁedmortalityinthe
10-year period after amputation from death certiﬁcate data. Diabetes was veriﬁed using World
HealthOrganizationcriteria.AmputationswereidentiﬁedbyICD-9-CMcodes84.11–84.18and
categorizedasfoot,below-kneeamputation,andabove-kneeamputationandveriﬁedbyreview-
ing medical records. We evaluated three levels of renal function: chronic kidney disease (CKD),
hemodialysis, and no renal disease. We deﬁned CKD based on a glomerular ﬁltration rate 60
ml/min and hemodialysis from Current Procedural Terminology (CPT) codes (90921, 90925,
90935,and90937).Weused
2fortrendandCoxregressionanalysistoevaluateriskfactorsfor
survival after amputation.
RESULTS — Patients with CKD and dialysis had more below-knee amputations and above-
knee amputations than patients with no renal disease (P  0.01). Survival was signiﬁcantly
higher in patients with no renal impairment (P  0.01). The Cox regression indicated a 290%
increase in hazard for death for dialysis treatment (hazard ratio [HR] 3.9, 95% CI 3.07–5.0) and
a 46% increase for CKD (HR 1.46, 95% CI 1.21–1.77). Subjects with an above-knee ampu-
tation had a 167% increase in hazard (HR 2.67, 95% CI 2.14–3.34), and below-knee
amputation patients had a 67% increase in hazard for death.
CONCLUSIONS — Survival after amputation is lower in diabetic patients with CKD, dial-
ysis, and high-level amputations.
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D
iabetes is the most common under-
lying cause of nontraumatic ampu-
tation in the U.S. and Europe (1–
4). Of the 120,000 amputations
performed in the U.S. every year, 40–
70% are in individuals with diabetes.
Among individuals with end-stage renal
diseasereceivingdialysis,theincidenceof
amputation is about 10 times higher than
in the general diabetic population (5).
The in-hospital and 30-day mortality
after amputation in people with diabetes
is higher than in people with coronary
artery bypass graft surgery, breast cancer,
or stroke (6–8). However, there is little
published data that report the long-term
survival after amputation and even less
data regarding patients with chronic kid-
ney disease (CKD). The purpose of this
study was to identify differences in the
proportion of amputations and survival
after lower-extremity amputation in indi-
viduals with diabetes and CKD and to
identify risk factors for survival after an
amputation.
RESEARCH DESIGN AND
METHODS— We abstracted and re-
viewed medical records for hospitaliza-
tions of diabetic patients requiring lower-
extremity amputations from 1 January to
31 December 1993 in six metropolitan
statistical areas in south Texas, including
San Antonio, Corpus Christi, Browns-
ville, McAllen, Laredo, and Victoria. Each
hospital in the study areas, including mil-
itary and Veterans Administration hospi-
talfacilities,providedalistofpatientsthat
had amputations in 1993. We also ab-
stracted medical records at the nearest
state hospital facility (University of Texas
MedicalBranch,Galveston,Texas)tover-
ifythatindigentoruninsuredpatientsdid
not leave their local community hospital
to receive care at a state facility. Only
threeamputeeswereidentiﬁedatthestate
hospital that lived in the geographic areas
being evaluated.
Amputations were identiﬁed from
ICD-9-CM codes and were categorized
by the level as foot (84.11–84.12), be-
low-knee (84.13–84.16), or above-
knee (84.17–84.18) (9). Operative
reports and medical records were re-
viewed to ascertain the amputation
level. Foot amputations were deﬁned as
amputations below the ankle, below-
knee amputations from the ankle to
through-knee amputations, and above-
knee amputations as amputations prox-
imal to through-knee procedures. For
individuals who had undergone multi-
ple amputations on the same extremity,
the highest level of amputation was
used in the analysis.
Race was recorded from the admit-
ting physician’s history and physical,
hospital admission database informa-
tion, and the nurse’s hospital admission
notes. History of previous ipsilateral or
contralateral lower-extremity amputa-
tion and the level of amputation were
identiﬁed from the physician’s and
nurse’s admission notes. A diagnosis of
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Health Organization criteria (10). Only
2.9% of amputees who had diabetes by
these criteria did not have a diabetes-
related ICD-9-CM code included in
their discharge summary.
We identiﬁed mortality from death
certiﬁcate information from the Social Se-
curityDeathIndex.Weidentiﬁedpatients
on hemodialysis by abstracting data from
their medical records and deﬁned CKD or
renal status based on the National Kid-
ney Disease Outcomes Quality Initiative
(NKDOQI)guidelinesasfollows:1)mildor
no CKD, estimated glomerular ﬁltration
rate (eGFR) 60 ml/min; 2) moderate-to-
severeCKD,eGFR60ml/minandsubject
is not on dialysis treatment (chronic CKD
group);and3)patientswithend-stagerenal
disease on dialysis treatment (dialysis
group). The eGFR was calculated using the
Modiﬁcation of Diet in Renal Disease for-
mula based on creatinine levels immedi-
ately before amputation, sex, and race (11).
We used a 
2 test for trend to com-
pare differences in the proportion of am-
putations by renal disease status (12). We
used an  of 0.05 and 95% CI in the anal-
ysis. In addition, a Cox proportional haz-
ard survival analysis was used to evaluate
differences in survival based on renal dis-
ease and amputation level; renal disease
and amputation level were represented as
ordinal categorical variables. A Cox pro-
portional hazard regression model (SPSS,
version 17) was used to evaluate risk
factors for 10-year mortality. In the anal-
ysis, multiple factors were examined us-
ing a forward stepwise procedure to
evaluate which factors were appropriate
for inclusion in the Cox regression. A
score statistic was used to enter factors
into a model, and a Wald statistic was
used to withdraw factors from the model.
Categorical variables for race, sex, level of
amputation, marital status, level of renal
disease, amputation history, peripheral
vascular disease, smoking history, dialy-
sis, cardiovascular disease, congestive
heartfailure,hypertension,andwhethera
bilateral amputation was performed were
used in the stepwise procedure. Each pa-
tient’s age was modeled as a continuous
covariate.
Table 1—Clinical characteristics and survival data
No CKD CKD Hemodialysis Total P
Demographics
n 526 389 128 1,043
Age mean  SD (range) 63.85  12.76 (27–96) 67.32  11.91 (35–97) 61.24  11.5 (30–84) 64.82  12.4 (27–97) 0.001
Sex (% male) 65.8 52.2 52.3 59.1 0.001
Race 0.066
African American 7.6 5.1 8.6 6.8 0.24
Hispanic 78.7 76.3 81.3 78.1 0.46
Caucasian 13.7 18.5 10.2 15.1 0.033
Comorbidities
Coronary heart disease 31.4 46.0 44.5 38.4 0.001
Hypertension 38.4 56.6 67.2 48.7 0.001
Stroke 15.0 17.0 13.3 15.5 0.5
Coronary heart failure 12.9 26.5 36.7 20.9 0.001
Diabetes medication
Insulin 45.8 55.3 60.9 51.2 0.001
Oral agents 41.3 29.6 20.3 34.3 0.001
Diet controlled 8.0 7.5 10.9 8.1 0.45
Surgery
Coronary bypass 7.6 13.4 20.3 11.3 0.001
Lower-extremity bypass 17.3 17.0 22.7 17.8 0.31
History of amputation 44.3 49.6 53.9 47.5 0.001
Bilateral amputation 24.7 30.1 36.7 28.2 0.015
Amputation by level
Foot 53.8 40.4 28.9 45.7 0.001
Below knee 27.0 35.7 43.8 32.3 0.001
Above knee 19.2 23.9 27.3 22.0 0.001
Percent survival after
amputation
1 year 85.6 76.6 50.8 77.9 0.001
2 years 77.0 67.1 42.2 69.0 0.001
3 years 73.2 56.3 28.9 61.5 0.001
4 years 66.0 48.6 20.3 53.9 0.001
5 years 60.3 40.9 17.2 47.7 0.001
6 years 53.8 34.4 14.8 41.8 0.001
7 years 47.1 27.8 12.5 35.7 0.001
8 years 43.5 21.9 10.2 31.4 0.001
9 years 36.7 19.8 10.2 27.1 0.001
10 years 32.9 17.0 9.4 24.1 0.001
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viduals with diabetes and an amputation
evaluated. The proportion of above-knee
and below-knee amputations was signiﬁ-
cantly higher in patients with CKD and
dialysis (Table 1). Survival rates after a
foot, below-knee, or above-knee amputa-
tion over 10 years are also listed in Table
1. In the survival analysis, individuals
with high-level amputations and individ-
uals with renal disease displayed signiﬁ-
cantly higher mortality rates than
individuals with lower-level amputations
and individuals without renal disease, re-
spectively (P  0.001, Figs. 1 and 2).
The Cox proportional hazard model
(Table 2) indicated that the hazard of
deathincreasedby3%foreachadditional
year postamputation for all study sub-
jects: the estimated hazard ratio (HR) was
1.03 (95% CI 1.02–1.04). When subjects
with no renal disease were used as the
reference group for comparison, the sur-
vival analysis indicated that there was a
290% increase in hazard for death for in-
dividuals on dialysis treatment (HR 3.9,
95% CI 3.07–5.0), and there was a 46%
increase in hazard for death for patients
with CKD (HR 1.46, 95% CI 1.21–1.77).
Compared with subjects with CKD, there
was a 160% increase in hazard among di-
alysis patients.
Taking foot level amputations as the
reference group for the survival analysis,
subjects with an above-knee amputation
had a 167% increase in hazard compared
with the reference group (HR 2.67, 95%
CI 2.14–3.34). Similarly, individuals
withabelow-kneeamputationhada67%
increase in hazard for death over baseline
(HR 1.67, 95% CI 1.36–2.06). Addition-
ally,goingfromabelow-kneeamputation
to an above-knee amputation increases
the hazard by 60% (HR 1.60, 95% CI
1.20–2.13).
CONCLUSIONS — The results of
this study suggest that renal disease,
higher level of amputation, and advanc-
ing age adversely affect survival after a
lower-extremity amputation in individu-
als with diabetes. Several studies have
identiﬁed a relationship between proxi-
mal amputation and decreased survival
(13–15). Our data provide additional in-
formation highlighting that this associa-
tion is more pronounced in subjects with
CKDlongitudinallyforeachyearandover
a 10-year period after an amputation.
There are only a handful of studies that
address long-term survival after amputa-
Figure 1—Survival function for CKD. There was signiﬁcantly higher mortality in dialysis pa-
tients and in patients with CKD than in patients with no kidney disease.
Figure 2—Survival function for amputation level. There was signiﬁcantly higher mortality in
patients with above-knee and below-knee amputations compared with foot amputations.
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ease among amputees.
Most of the existing work reports in-
hospital or 30-day survival after amputa-
tion. In a study of 8,169 hospitalizations
in California for lower-extremity amputa-
tion, we found that in-hospital mortality
in individuals with diabetes was higher as
amputation level increased (foot 1.5%,
leg 4%, and thigh 7%) (9). Mayﬁeld et al.
(13)reported3-yearsurvivalresultsdem-
onstrating the same trend (foot 54%, leg
44%, and thigh 30%); however, neither
study reported level speciﬁc rates for pa-
tients based on presence or severity of re-
nal disease (9,13). Our ﬁrst-year survival
rateforthehemodialysispatients(50.8%)
is in agreement with that of an observa-
tional report by McGrath and Curran
(16). In this study, the authors retrospec-
tively reviewed 47 diabetic patients who
had had an amputation, 86% (32 pa-
tients)ofwhomwereMaorisand30%(14
patients) were on dialysis. Seven out of
the 14 patients on dialysis died within 1
year after amputation, giving a ﬁrst-year
mortality of 50%. However, the number
of patients included in this study was
small.
O’Hare et al. (6) identiﬁed a 30-day
postoperative amputation mortality of
16% in dialysis patients and 6% in indi-
viduals with diabetes and no renal dis-
ease, but did not evaluate level-speciﬁc
rates. Patients with CKD probably have
more severe diabetes-related comorbidi-
ties, so a high-level amputation and mor-
talitymayreﬂecttheseverityofperipheral
vascular disease, neuropathy, cardiovas-
cular disease, or poor response to infec-
tion (17).
It is noteworthy that mortality rates
for some severe diseases are lower than
those reported in patients with diabetes
and end-stage renal disease postamputa-
tion. For instance, 1-, 3-, and 5-year sur-
vival rates after hospital admission for
heart failure in patients with diabetes are
77,50,and32%,respectively(18);5-year
mortality after myocardial infarction in
patients with diabetes is 72% (19); and
5-year survival after ischemic stroke has
been reported to be 59.5% (20). Among
dialysis patients, the 1- and 5-year sur-
vival is 79 and 68%, respectively (21);
however,forpatientswithdiabetesonhe-
modialysis, 5-year survival is only 54%
(22). Our study similarly suggests a more
dismal prognosis within dialysis ampu-
teescomparedwithnondialyzedsubjects.
One-year survival was 50.8% among di-
alysis amputees, 76.6% among amputees
with CKD, and 85.6% among amputees
without CKD.
In addition, our overall 1-year (78%)
and 5-year (48%) survival rates are simi-
lar to those found by Hambleton et al.
(23) (69 and 44%, respectively) in their
study of Caribbean blacks in Barbados,
butlowerthanthatreportedforAmerican
Indians (24). At ﬁrst sight, this may ap-
pearcounterintuitivebecauseblacks,par-
ticularly in developing countries, would
be expected to have higher mortality
rates. However, Hambleton et al. alluded
to the possibility of a different hierarchy
of postamputation complications in the
developingworld.Theysuggestedthatin-
fection contributed as much to mortality
as cardiovascular disease, the traditional
cause of postamputation mortality in the
western world. This corroborates our
ﬁndingsthatdialysisisassociatedwithin-
creasedmortality,sinceindividualsondi-
alysis are more prone to developing
infections (25).
There are several limitations to this
study that are inherent in retrospective
audits of medical records. It is unclear if
our ﬁndings are generalizable to other
ethnic/racial groups in the U.S. The vast
majority of the study population was His-
panic. Although there is a growing His-
panic population in the U.S., the
characteristics of the population and
medicalresourcesinsouthTexasmaynot
reﬂect the mortality experience or risk
factors observed in other parts of the
country. The most important limitations
involved missing data and inconsistent
deﬁnitions of pivotal risk factors. Impor-
tant explanatory variables such as the se-
verity of vascular disease, neuropathy,
glucose control, duration of diabetes,
heartdisease,andinfectionwereoftennot
identiﬁed and may have been underre-
ported.WeusedtheSocialSecurityDeath
Index to identify mortality. Mortality data
couldnotbeveriﬁed.Inaddition,wemay
have missed study subjects who returned
toMexicobeforetheydied.Thesepatients
may not have been reported in the death
index we used. However, we believe that
their inclusion would have further mag-
niﬁed a high mortality rate that is already
apparent.Ontheotherhand,datasuchas
the presence of diabetes and level of am-
putation were easily identiﬁed in the
medical records because they were well-
documented multiple times through lab-
oratory reports, ICD-9-CM codes, and
operative reports.
Our data provide further evidence
that CKD and dialysis treatment are inde-
pendent risk factors for mortality after
lower-extremity amputation. We also
showed that the 10-year mortality among
patients on dialysis who have an amputa-
tion was three times greater than patients
who require amputation without CKD.
Mortalityinthispopulationishigherthan
many other disease processes such as cor-
onary artery disease, stroke, and cancer
(6–8). Future research speciﬁc to pa-
tients with CKD will help us determine
which prevention strategies and wound
therapies will improve amputation pre-
vention in this high-risk population.
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